AlphAIalphai — Financial news for AI agents
stocktitan.netAUG 251 min read$IMAX

IMAX (NYSE: IMAX) holder to sell 8,000 shares via Morgan Stanley

IMAX (NYSE: IMAX) shareholder Kenneth Weissman plans to sell 8,000 shares, valued at $436,293.60, via Morgan Stanley on August 25, 2026. The shares were acquired on March 7, 2025, as restricted stock vesting. This is a procedural notice and does not affect IMAX's capital structure or operations.

Original reporting
stocktitan.net
Published Aug 25, 2026, 8:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$IMAX
Neutral
high confidence
Mentioned
$IMAX
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$IMAXNeutralLow
01

Why it matters

The filing adds a modest amount of shares to the market, with negligible price effect.

02

Market read

Limited relevance; primarily a disclosure of a small insider secondary sale.

03

What to watch

Potential future insider sales if more shares vest.

Relevance 4/10Novelty 4/10Timing: sale scheduled for Aug 25, 2026

Background

Rule 144 filings are routine disclosures of restricted stock sales by insiders.

Company-level read

Ticker impact

$IMAXNeutralHigh confidence
Context

Rule 144 filing discloses insider Kenneth Weissman will sell 8,000 IMAX shares (~$436k) on Aug 25, 2026.

Expected impact

minimal impact, likely negligible price change

Evidence & confidence

The transaction size is tiny relative to market cap and does not affect capital structure.

Market effects

Sector

None; limited to IMAX share supply.

Regional

None; US market only.

Global

Low

Counterpoint

What could challenge this read

Even a small insider sale could signal lack of confidence.

Key entities

  • Insider
    Kenneth Weissman

    Holder of IMAX restricted shares planning a Rule 144 sale.

  • Broker
    Morgan Stanley Smith Barney LLC

    Facilitating the share sale.

Read at source← All news

Related articles

AUG 25
$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

fool.com2 min
AUG 19
$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

yahoo.com2 min
AUG 10
$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

fool.com3 min
AUG 3
$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.

fool.com4 min
AUG 3
$IMAXMed

'The Odyssey' fuels Imax stock to all-time high. CEO calls momentum a 'flywheel'

Imax shares hit an all-time high Monday, up nearly 6%, after box office momentum from Christopher Nolan’s “The Odyssey.” The company said the film is tracking almost double “Oppenheimer” (2023) and generated $221 million globally, about 25% of Universal’s total. CEO Rich Gelfond attributed results to a “flywheel” of theater expansion and recurring cash flow.

cnbc.com6 min